Liver Transplant Program and Center for Liver Disease
Liver Newsletter

Ecstasy: a Common Cause of Severe Acute Hepatotoxicity. Andreu et al. (Barcelona) J. Hepatol. 29:394-397, 1998.
Ecstasy is a synthetic amphetamine used as a recreational drug. 62 patients with acute liver failure seen in a three-year period were reviewed. Viral hepatitis was diagnosed in 30, toxic hepatitis in 11 (anti-tuberculous agents in 6, acetaminophen overdose in one, halothane in 2 and amainita poisoning in 1, etc.), miscellaneous causes in 6, and undetermined origin in 10. Of the latter group, five were associated with ecstasy consumption, representing 5 of 16 due to toxic agents (31%). They presented after a short prodrome with abdominal pain and jaundice. All had ALT >2500 (u/l), hypoglycemia, and protime <50%. Latency was 1-2 weeks after ingestion. None developed encephalopathy. Dosage varies from one tablet to regular use for weeks or months. One positive rechallenge occurred. In Spain, ecstasy accounts for the majority of severe hepatitis cases of toxic origin.





Home Page 
 Areas of Expertise 
Bloodless Surgery 
Liver Transplantation 
Live Donor Liver Transplant 
Liver Surgery 
Pancreatic Surgery 
Gallbladder/Bile Duct Surgery 
Portal Hypertension Surgery 
Radio Frequency Ablation 
Endoscopic Retrograde
   Cholangiopancreatography
 
Pediatric Surgery
   and Transplant
 
 Information for Patients 
Transplant Patient Guide 
Long-Term Transplant Care 
Patient Support Groups 
Financial Considerations 
Liver Glossary 
About the USC
   University Hospital
 
 Features 
What's New 
Research and Development 
Liver Newsletter 
Downloads 
 General Information 
Faculty and Staff 
Web Links 
Site Map 
Contact Us 
 Search this site 

University of Southern California USC Liver Transplant Program and Center for Liver Disease
1510 San Pablo Street, Suite 200, Los Angeles CA 90033-4612
Phone: (323) 442-5908     Fax: (323) 442-5721
E-mail: uscliver@surgery.hsc.usc.edu